Smith Jason Drewinsider trades

In SEC Form 4 filings, Smith Jason Drew is listed as General Counsel of UroGen Pharma Ltd. (URGN). In the last 90 days, Smith Jason Drew sold $64.6K of UroGen Pharma Ltd. (URGN) on the open market and bought none.

Companies and roles

Company	Role	Transactions	Last filed
URGNUroGen Pharma Ltd.	General Counsel	3	Sep 9

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-09

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
URGNUroGen Pharma Ltd.	Sep 8	Sep 9	S	1,519	$42.54	Sale −$64,618	53,141	No	Form 4
URGNUroGen Pharma Ltd.	Sep 7	Sep 9	M	3,334	not reported	not reported	54,660	No	Form 4
URGNUroGen Pharma Ltd.	Sep 7	Sep 9	M · derivative	3,334	$0.00	$0	not reported	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.